ELV Factor-Based Stock Analysis

Validea's guru fundamental report identifies Elevance Health Inc (ELV), a large-cap growth stock in the Insurance (Accident & Health) industry, as its highest-rated stock using the John Neff-inspired Low PE Investor model. ELV achieved a 79% rating, signaling potential interest as it nears the 80% threshold for 'some interest,' based on its underlying fundamentals and valuation against the model's criteria for persistent earnings growth at a discount. While the stock passed key metrics such as P/E ratio and EPS growth, it notably failed tests for Total Return/PE and EPS Persistence.

Analysis

Elevance Health (ELV) has been flagged by Validea's quantitative screening as a stock of interest, securing a 79% rating based on a model inspired by John Neff's low P/E investment strategy. This score, which approaches the 80% threshold for 'some interest,' reflects a fundamentally strong but imperfect profile. The company, a large-cap in the health insurance sector, passes key tests for its Price-to-Earnings ratio, current and future EPS growth, sales growth, and free cash flow, indicating robust operational performance and positive forward-looking metrics. However, the analysis reveals two notable weaknesses: the stock fails the criteria for 'Total Return/PE' and 'EPS Persistence.' The failure on total return relative to P/E suggests the stock's valuation may not be sufficiently discounted when accounting for its dividend and growth profile. More critically, the lack of EPS persistence indicates that historical earnings growth has been inconsistent, a significant deviation from the Neff model's preference for steady, predictable performance.

Key Decisions for Investors

• Given the positive signals on growth, free cash flow, and P/E ratio, investors may consider ELV a candidate for a Growth at a Reasonable Price (GARP) portfolio, pending further due diligence.
• The failure on 'EPS Persistence' is a key red flag; investors should scrutinize the historical volatility of ELV's earnings to assess whether the inconsistency is a systemic issue or a temporary anomaly before committing capital.
• As the 79% score is just below the model's 80% interest threshold, investors could place ELV on a watchlist, as any improvement in earnings consistency or a more favorable total return-to-P/E ratio could trigger a stronger quantitative buy signal.
• The 'Total Return/PE' failure suggests valuation may be a constraint, so investors should model their own total return expectations to determine if the current entry point offers a sufficient margin of safety.